The role of magnetic resonance imaging in prostate cancer imaging and staging

Robert E. Lenkinski

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2 Citations (Scopus)

Abstract

MRI of the prostate can be used to address several of the clinical issues associated with diagnosing and treating prostate cancer. We have found dynamic contrast enhanced MRI (DCEMRI) to be valuable tool in visualizing and characterizing malignancies. Our approach is based on the threetime point method (3TP), which is a simplified model based method for analyzing DCEMRI of the prostate. This method is a high-spatial, low temporal resolution approach. We have found that this approach can be combined with more conventional MRI methods to give highly accurate staging of prostate cancer. An unanticipated clinical benefit has been the ability to use DCEMRI to image men with elevated PSA and repeat negative biopsy. We have also used a model independent approach based on principal component analysis (PCA) to analyze the DCEMRI datasets.

Original languageEnglish (US)
Title of host publicationProceedings - International Symposium on Biomedical Imaging
Pages2109-2112
Number of pages4
DOIs
StatePublished - 2011
Event2011 8th IEEE International Symposium on Biomedical Imaging: From Nano to Macro, ISBI'11 - Chicago, IL, United States
Duration: Mar 30 2011Apr 2 2011

Other

Other2011 8th IEEE International Symposium on Biomedical Imaging: From Nano to Macro, ISBI'11
CountryUnited States
CityChicago, IL
Period3/30/114/2/11

Fingerprint

Neoplasm Staging
Magnetic resonance
Magnetic resonance imaging
Prostatic Neoplasms
Magnetic Resonance Imaging
Imaging techniques
Prostate
Principal Component Analysis
Biopsy
Principal component analysis
Neoplasms

ASJC Scopus subject areas

  • Biomedical Engineering
  • Radiology Nuclear Medicine and imaging

Cite this

Lenkinski, R. E. (2011). The role of magnetic resonance imaging in prostate cancer imaging and staging. In Proceedings - International Symposium on Biomedical Imaging (pp. 2109-2112). [5872829] https://doi.org/10.1109/ISBI.2011.5872829

The role of magnetic resonance imaging in prostate cancer imaging and staging. / Lenkinski, Robert E.

Proceedings - International Symposium on Biomedical Imaging. 2011. p. 2109-2112 5872829.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Lenkinski, RE 2011, The role of magnetic resonance imaging in prostate cancer imaging and staging. in Proceedings - International Symposium on Biomedical Imaging., 5872829, pp. 2109-2112, 2011 8th IEEE International Symposium on Biomedical Imaging: From Nano to Macro, ISBI'11, Chicago, IL, United States, 3/30/11. https://doi.org/10.1109/ISBI.2011.5872829
Lenkinski RE. The role of magnetic resonance imaging in prostate cancer imaging and staging. In Proceedings - International Symposium on Biomedical Imaging. 2011. p. 2109-2112. 5872829 https://doi.org/10.1109/ISBI.2011.5872829
Lenkinski, Robert E. / The role of magnetic resonance imaging in prostate cancer imaging and staging. Proceedings - International Symposium on Biomedical Imaging. 2011. pp. 2109-2112
@inproceedings{f7931321a9284bebba0b22fff52a1aac,
title = "The role of magnetic resonance imaging in prostate cancer imaging and staging",
abstract = "MRI of the prostate can be used to address several of the clinical issues associated with diagnosing and treating prostate cancer. We have found dynamic contrast enhanced MRI (DCEMRI) to be valuable tool in visualizing and characterizing malignancies. Our approach is based on the threetime point method (3TP), which is a simplified model based method for analyzing DCEMRI of the prostate. This method is a high-spatial, low temporal resolution approach. We have found that this approach can be combined with more conventional MRI methods to give highly accurate staging of prostate cancer. An unanticipated clinical benefit has been the ability to use DCEMRI to image men with elevated PSA and repeat negative biopsy. We have also used a model independent approach based on principal component analysis (PCA) to analyze the DCEMRI datasets.",
author = "Lenkinski, {Robert E.}",
year = "2011",
doi = "10.1109/ISBI.2011.5872829",
language = "English (US)",
isbn = "9781424441280",
pages = "2109--2112",
booktitle = "Proceedings - International Symposium on Biomedical Imaging",

}

TY - GEN

T1 - The role of magnetic resonance imaging in prostate cancer imaging and staging

AU - Lenkinski, Robert E.

PY - 2011

Y1 - 2011

N2 - MRI of the prostate can be used to address several of the clinical issues associated with diagnosing and treating prostate cancer. We have found dynamic contrast enhanced MRI (DCEMRI) to be valuable tool in visualizing and characterizing malignancies. Our approach is based on the threetime point method (3TP), which is a simplified model based method for analyzing DCEMRI of the prostate. This method is a high-spatial, low temporal resolution approach. We have found that this approach can be combined with more conventional MRI methods to give highly accurate staging of prostate cancer. An unanticipated clinical benefit has been the ability to use DCEMRI to image men with elevated PSA and repeat negative biopsy. We have also used a model independent approach based on principal component analysis (PCA) to analyze the DCEMRI datasets.

AB - MRI of the prostate can be used to address several of the clinical issues associated with diagnosing and treating prostate cancer. We have found dynamic contrast enhanced MRI (DCEMRI) to be valuable tool in visualizing and characterizing malignancies. Our approach is based on the threetime point method (3TP), which is a simplified model based method for analyzing DCEMRI of the prostate. This method is a high-spatial, low temporal resolution approach. We have found that this approach can be combined with more conventional MRI methods to give highly accurate staging of prostate cancer. An unanticipated clinical benefit has been the ability to use DCEMRI to image men with elevated PSA and repeat negative biopsy. We have also used a model independent approach based on principal component analysis (PCA) to analyze the DCEMRI datasets.

UR - http://www.scopus.com/inward/record.url?scp=80055030859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055030859&partnerID=8YFLogxK

U2 - 10.1109/ISBI.2011.5872829

DO - 10.1109/ISBI.2011.5872829

M3 - Conference contribution

AN - SCOPUS:80055030859

SN - 9781424441280

SP - 2109

EP - 2112

BT - Proceedings - International Symposium on Biomedical Imaging

ER -